SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-023333
Filing Date
2024-06-10
Accepted
2024-06-10 16:05:13
Documents
13
Period of Report
2024-06-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39740
  Complete submission text file 0001493152-24-023333.txt   216796

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ser-20240606.xsd EX-101.SCH 3042
3 XBRL LABEL FILE ser-20240606_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ser-20240606_pre.xml EX-101.PRE 22378
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3802
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 241032658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)